Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis

被引:11
作者
Fan, Lili [1 ,2 ]
Lei, Han [1 ]
Lin, Ying [1 ]
Zhou, Zhengwei [1 ]
Li, Juanni [1 ]
Wu, Anqi [1 ]
Shu, Guang [1 ]
Roger, Sebastien [3 ]
Yin, Gang [1 ]
机构
[1] Cent South Univ Hunan Prov, Sch Basic Med Sci, Dept Pathol, Xiangya Hosp, Changsha 410000, Peoples R China
[2] Jinan Univ, Sch Tradit Chinese Med, Guangzhou Key Lab Formula Pattern Tradit Chinese, Guangzhou 510632, Guangdong, Peoples R China
[3] Univ Tours, Inflammat, Immunol, EA4245 Transplantat, F-37032 Tours, France
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Ovarian cancer; Hotair; miR-222-3p; CDK19; axis; Proliferation; Migration; CYCLIN-DEPENDENT KINASES; NONCODING RNA HOTAIR; LNCRNA HOTAIR; CELL-CYCLE; EXPRESSION; MICRORNAS; FUTURE; GENES;
D O I
10.1007/s00018-022-04250-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies in our laboratory have reported that miR-222-3p was a tumor-suppressive miRNA in OC. This study aims to further understand the regulatory role of miR-222-3p in OC and provide a new mechanism for its prevention and treatment. We first found that miR-222-3p inhibited the migration and proliferation of OC cells. Then, we observed CDK19 was highly expressed in OC and inversely correlated with miR-222-3p. Besides, we observed that miR-222-3p directly binds to the 3 '-UTR of CDK19 and inhibits CDK19 translation, thus inhibiting OC cell migration and proliferation in vitro and repressed tumor growth in vivo. We also observed the inhibitory effect of Hotair on miR-222-3p in OC. In addition, Hotair could promote the proliferation and migration of OC cells in vitro and facilitate the growth and metastasis of tumors in vivo. Moreover, Hotair was positively correlated with CDK19 expression. These results suggest Hotair indirectly up-regulates CDK19 through sponging miR-222-3p, which enhances the malignant behavior of OC. This provides a further understanding of the mechanism of the occurrence and development of OC.
引用
收藏
页数:15
相关论文
共 43 条
[1]   Expression Analysis of MicroRNA-222 in Breast Cancer [J].
Amini, Sima ;
Abak, Atefeh ;
Estiar, Mehrdad A. ;
Montazeri, Vahid ;
Abhari, Alireza ;
Sakhinia, Ebrahim .
CLINICAL LABORATORY, 2018, 64 (04) :491-496
[2]   The history and future of targeting cyclin-dependent kinases in cancer therapy [J].
Asghar, Uzma ;
Witkiewicz, Agnieszka K. ;
Turner, Nicholas C. ;
Knudsen, Erik S. .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (02) :130-146
[3]   LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer [J].
Bhan, Arunoday ;
Mandal, Subhrangsu S. .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1856 (01) :151-164
[4]   MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease [J].
Bhaskaran, M. ;
Mohan, M. .
VETERINARY PATHOLOGY, 2014, 51 (04) :759-774
[5]   LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer [J].
Chang, Lei ;
Guo, Ruixia ;
Yuan, Zhongfu ;
Shi, Huirong ;
Zhang, Dongya .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (04) :1289-1303
[6]   Global ovarian cancer health disparities [J].
Chornokur, Ganna ;
Amankwah, Ernest K. ;
Schildkraut, Joellen M. ;
Phelan, Catherine M. .
GYNECOLOGIC ONCOLOGY, 2013, 129 (01) :258-264
[7]   MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis [J].
de Conti, Aline ;
Ortega, Juliana Festa ;
Tryndyak, Volodymyr ;
Dreval, Kostiantyn ;
Moreno, Fernando Salvador ;
Rusyn, Ivan ;
Beland, Frederick A. ;
Pogribny, Igor P. .
ONCOTARGET, 2017, 8 (51) :88517-88528
[8]   HOTAIR Promotes Proliferation, Migration, and Invasion of Ovarian Cancer SKOV3 Cells Through Regulating PIK3R3 [J].
Dong, Lijun ;
Hu, Lina .
MEDICAL SCIENCE MONITOR, 2016, 22 :325-331
[9]   Emerging Roles for Natural MicroRNA Sponges [J].
Ebert, Margaret S. ;
Sharp, Phillip A. .
CURRENT BIOLOGY, 2010, 20 (19) :R858-R861
[10]   Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10 [J].
Fan, Lili ;
Lei, Han ;
Zhang, Sai ;
Peng, Yulong ;
Fu, Chunyan ;
Shu, Guang ;
Yin, Gang .
THERANOSTICS, 2020, 10 (13) :5895-5913